Study Title
A Study of Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18F-DCFPyL
Study Details
Description:
Prostate cancer is the second leading cause of cancer-related death in American men. The disease recurs in up to 50,000 men each year after their early-stage disease was treated; however, at this stage, imaging scans are often unable to find the disease in the body. In this natural history study, researchers want to find out if a new radiotracer (18F-DCFPyL) injected before positron emission tomography (PET) imaging can help identify sites in the body with cancer.
Sponsor:
National Cancer Institute
Contacts:
Amy R Hankin, P.A.-Camy.hankin@nih.gov
(240) 858-3149
Ravi A Madan, M.D. (Principal Investigator)rm480i@nih.gov
(301) 480-7168
Government Study Link:
NCT05588128 - Click here to see study onClinicalTrials.gov